Proteasome inhibitor and immunomodulatory agent
This page covers all Proteasome inhibitor and immunomodulatory agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Proteasome and cereblon.
Targets
Marketed (1)
- Ixazomib plus low-dose lenalidomide · Second Affiliated Hospital, School of Medicine, Zhejiang University
Patent intelligence
- proteasome inhibitor and immunomodulatory agent patent landscape — aggregated cliff calendar, attackable patents, originator estates